2024
-
New Findings Implicate XIST in Female Sex-Based Autoimmunity
Being born female increases risk of autoimmune disease four-fold compared to males. Montserrat C. Anguera, PhD, opened a session on research indicating flaws in the mechanism that protects females from overexposure to their own X chromosomes are the cause.
-
Experts Debate the Value of Medical Versus Behavioral Lifestyle Interventions for Patients with Obesity and OA
Prescribing a medication to stimulate weight loss is a convenient option for patients, but clinicians must also account for factors such as cost and the long-term welfare of their patients. Stephen Messier, PhD, and Martin Englund, MD, PhD, weighed the merits of these therapeutic philosophies.
-
Interactive Session Addresses Challenging Cases of Pediatric Lupus
Incomplete renal response, prolonged time to renal response, renal flares, steroid toxicity, tolerability and adherence, and the lack of data in the pediatric population complicate the management of young patients with severe lupus nephritis, said Stacy Ardoin, MD.
-
Investigators Analyze the Current and Future Landscapes of Genetic Testing
Experts including Troy Torgerson, MD, PhD, shared insights for optimal genetic testing strategies in the era of inborn errors of immunity, as well as challenges they hope to overcome in the future.
-
Session to Provide Update on CNS Angiitis in Children
Eyal Muscal, MD, MS, will review clinical features and novel biomarkers of pediatric primary angiitis of the central nervous system in a session that will explore the diagnostic schema and treatment regimens that can support clinicians in recognizing and treating the disease more efficiently.
-
Pioneer in B-Cell Function and Therapeutic Targeting in Autoimmune Disease Will Share Cutting-Edge Research on RA Synovitis
Jennifer Anolik, MD, PhD, will discuss the latest findings on rheumatoid arthritis pathogenesis and progression obtained via detailed characterization of patient-derived synovial tissue samples in this State-of-the-Art lecture.
-
International Panel Will Detail How Multidisciplinary Strategies for Navigating OA Differ Across the Globe
Osteoarthritis is the most widespread form of rheumatic disease without a cure. Experts from North America and Europe, including Rikke Helene Moe, PhD, of Norway, will discuss the interprofessional approaches used in different countries to care for patients living with the disease.
-
Session to Detail How the Patient Perspective Can Transform Rheumatology Care and Research
Experts, including patient advocate Eileen Davidson, will explain how the patient’s perspective is fundamental to making advances in the field, whether it’s understanding practical issues that patients grapple with daily or providing a different interpretation of data.
-
Former ARP Presidents Analyze Successes and Challenges of the Past to Build for the Future
Donning small plastic sprouts symbolizing optimism and a spirit of growth, former ARP presidents, including Teresa Brady, PhD, MACR, led a session highlighting achievements among rheumatology professionals and within the ARP over the past 35 years as a way of putting into perspective the current…
-
FDA Gives Updates on Newly Approved Agents for Rheumatic Diseases
The U.S. Food and Drug Administration approved indications for adult and pediatric rheumatology as well as new biosimilars and interchangeables for the treatment of rheumatic disease. Erick J. Gapud, MD, PhD, provided an overview of these drugs.